Development and Evaluation of a Lyophilized Plasma-Based Internal Quality Control for Human Immunodeficiency Virus

Siriphailin Jomjunyoung1,2, Wanvisa Treebuphachatsakul1,3, Supaporn Suparak2

  • 1Reference Materials and Innovation Research Unit for Medical Laboratory, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.

PubMed

Insights

New internal quality control (IQC) materials for human immunodeficiency virus (HIV) rapid diagnostic tests (RDTs) were developed. Trehalose-stabilized lyophilized plasma showed long-term stability, compatible with multiple HIV RDT brands without cold-chain needs.

Area of Science:

  • Clinical diagnostics
  • Biotechnology
  • Immunology

Background:

  • Rapid diagnostic tests (RDTs) for human immunodeficiency virus (HIV) are crucial for widespread screening.
  • Most commercially available HIV RDT kits lack standardized internal quality control (IQC) materials.
  • The absence of reliable IQC hinders accurate and consistent test performance.

Purpose of the Study:

  • To develop and evaluate a stable, plasma-based IQC material for HIV RDTs.
  • To ensure compatibility of the developed IQC with multiple leading HIV RDT brands.
  • To assess the long-term stability of the IQC material under various storage conditions.

Main Methods:

  • Three reactivity levels of plasma control samples were prepared in lyophilized and liquid forms.
  • Lyophilized samples were formulated with or without trehalose; liquid samples with or without a stabilizer.
  • Accelerated stability testing at 37°C and 45°C for 28 days, followed by long-term storage assessment at 4°C and 25°C.
  • Stability was determined by analyzing test-line visibility and signal intensity using linear regression (p > 0.05 for stability).

Main Results:

  • Trehalose-containing lyophilized plasma samples demonstrated consistent reactivity and signal intensity.
  • These samples maintained stability during accelerated testing (37°C, 45°C) and for 6 months at 4°C and 25°C.
  • No significant changes in signal intensity were observed (p > 0.05), indicating high stability.

Conclusions:

  • Developed plasma-based IQC materials are compatible with five major HIV RDT brands.
  • Trehalose-stabilized lyophilized plasma exhibits excellent long-term stability.
  • This IQC formulation supports simplified transport and storage, potentially without requiring a strict cold chain.